论文部分内容阅读
据Kole AJ 2011年1月25日(Genes Dev,2011,25:125-130.doi:10.1101/gad.1975411)报道,北卡罗莱纳大学研究人员最近发现了一种能使脑细胞抵抗程序性细胞死亡的新分子,该发现预示着一种新的治疗方法,能使神经退行性病变和卒中患者脑细胞存活率大大提高。主要研究者是北卡罗莱纳大学细胞与发展生物学副教授莫哈尼斯.戴斯穆克。程序性死亡是有机体为维持内环境稳定,由基因控制的细胞自主的有序性死亡。新分子称为微型核糖核酸-29(miR-29),是一
According to Kole AJ, January 25, 2011 (Genes Dev, 2011, 25: 125-130. Doi: 10.1101 / gad. 197541), researchers at the University of North Carolina have recently discovered a pathway that allows brain cells to resist programmed The new molecule of cell death, the findings heralded a new therapeutic approach that dramatically increases brain cell survival in neurodegenerative and stroke patients. The principal investigator is Mohannis Desmuck, associate professor of cell and developmental biology at the University of North Carolina. Programmed death is the organism’s orderly death that is controlled by gene-controlled cells in order to maintain stable internal environment. The new molecule, called mini-RNA-29 (miR-29), is one